Aptevo Therapeutics Inc. (APVO)
Stock Price: $23.52 USD
0.07 (0.30%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Numbers in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.31 | - | 23.07 | 14.66 | 9.99 | 33.60 | 45.63 | 0.17 | |
| Revenue Growth | - | - | 57.37% | 46.8% | -70.28% | -26.36% | 26741.76% | - | |
| Cost of Revenue | - | - | 11.21 | 5.01 | 12.47 | 16.93 | 16.25 | - | |
| Gross Profit | 4.31 | - | 11.85 | 9.65 | -2.48 | 16.67 | 29.38 | 0.17 | |
| Selling, General & Admin | 13.95 | 16.20 | 28.13 | 34.58 | 36.16 | 43.04 | 34.28 | 15.45 | |
| Research & Development | 17.85 | 24.76 | 35.39 | 29.02 | 29.12 | 34.73 | 46.59 | 38.07 | |
| Other Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 71.01 | 0.00 | 0.22 | -0.02 | |
| Operating Expenses | 31.80 | 40.96 | 63.52 | 63.60 | 136 | 77.77 | 81.09 | 53.51 | |
| Operating Income | -27.49 | -40.96 | -51.67 | -53.95 | -139 | -61.10 | -51.71 | -53.34 | |
| Other Expense / Income | -9.74 | -0.51 | 2.02 | -37.62 | -6.67 | 0.24 | 0.00 | 0.00 | |
| Pretax Income | -17.75 | -40.45 | -53.69 | -16.33 | -132 | -61.34 | -51.71 | -53.34 | |
| Income Tax | - | - | - | -23.30 | -19.69 | -2.02 | -0.60 | - | |
| Net Income | -17.75 | -40.45 | -53.69 | 6.97 | -112 | -59.32 | -51.12 | -53.34 | |
| Shares Outstanding (Basic) | 3.39 | 2.92 | 1.61 | 1.52 | 1.45 | 1.44 | - | - | |
| Shares Outstanding (Diluted) | 3.39 | 2.92 | 1.61 | 1.52 | 1.45 | 1.44 | - | - | |
| Shares Change | 16.25% | 81.5% | 5.46% | 5.42% | 0.05% | - | - | - | |
| EPS (Basic) | -5.23 | -13.86 | -33.46 | 4.62 | -77.70 | -41.02 | - | - | |
| EPS (Diluted) | -5.23 | -13.86 | -33.46 | 4.62 | -77.70 | -41.02 | - | - | |
| Free Cash Flow Per Share | -8.67 | -14.58 | -32.60 | -28.20 | -27.24 | -34.80 | - | - | |
| Gross Margin | 100% | - | 51.4% | 65.8% | -24.9% | 49.6% | 64.4% | 100% | |
| Operating Margin | -638.1% | - | -224.0% | -368.1% | -1,389.8% | -181.8% | -113.3% | -31,374.7% | |
| Profit Margin | -411.9% | - | -232.8% | 47.6% | -1125.8% | -176.5% | -112% | -31374.7% | |
| FCF Margin | -682.4% | - | -227.2% | -293.2% | -394.3% | -149.7% | -105.2% | -30,831.2% | |
| EBITDA | -16.34 | -38.21 | -51.30 | -13.20 | -129 | -58.43 | -49.69 | -52.67 | |
| EBITDA Margin | -379.3% | - | -222.4% | -90.1% | -1289.4% | -173.9% | -108.9% | -30982.9% | |
| EBIT | -17.75 | -40.45 | -53.69 | -16.33 | -132 | -61.34 | -51.71 | -53.34 | |
| EBIT Margin | -411.9% | - | -232.8% | -111.4% | -1,323.1% | -182.5% | -113.3% | -31,374.7% |